If you're experiencing drenching sweats that disrupt your sleep, Doctronic can help identify the underlying cause and appropriate treatment options
Carita AC, Eloy JO, Chorilli M, Lee RJ, Leonardi GR
On May 13, at the 33rd European Congress on Obesity in Istanbul, Trkiye, findings from the Phase III SURMOUNT-MAINTAIN trial (NCT06047548) were presented, evaluating the use of Eli Lilly's Zepbound (tirzepatide) in sustaining weight loss following an initial 60-week open-label weight-loss period
Storage and handling for tirzepatide niacinamide Proper storage is essential to maintain peptide stability and efficacy
however, this pattern shifted in 2023 when both T2DM and the second most common diagnosis, hypertension, were surpassed by obesity (47.1%)